Search

Your search keyword '"Pico, Antonio"' showing total 104 results
Start Over Author "Pico, Antonio"
104 results on '"Pico, Antonio"'

4. Outcomes of transsphenoidal surgery for producing pituitary adenomas in spain

Author

Paja, Fano Miguel, primary, Hanzu, Felicia, additional, Angeles, Galvez Mª, additional, Villar, Rocio, additional, Moure, Dolores, additional, Menendez, Edelmiro, additional, Gonzalez-Fernandez, Laura, additional, Egana, Nerea, additional, Camara, Rosa, additional, Penalver, David, additional, Simo, Andreu, additional, Asensio-Wandosell, Diego, additional, Tenorio, Carmen, additional, Novo, Cristina, additional, Calatayud, Maria, additional, Pico, Antonio, additional, Sottile, Johana, additional, Diaz-Soto, Gonzalo, additional, Araujo-Castro, Marta, additional, Soto, Alfonso, additional, De, Pablos Pedro, additional, Aulinas, Anna, additional, Munoz, Fernando, additional, and Biagetti, Betina, additional

Published
2024
Full Text
View/download PDF

8. THU283 Oral Semaglutide, Effectiveness, Safety And Tolerability In Real Life: A Short-term Retrospective Observational Study

Author

Moreno-Perez, Oscar, primary, Guillen-Morote, Cristina, additional, Argüello, Thalía, additional, Soriano, Carmen, additional, SantaCruz, Elisa, additional, Lopez-Mondejar, Pedro, additional, Navarro-Hoyas, Clara, additional, Sanchez-Ortiga, Ruth, additional, Sanchez-Pacheco, Myriam, additional, Modrego-Pardo, Ines, additional, and Miguel Pico, Antonio, additional

Published
2023
Full Text
View/download PDF

11. Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study

Author

Puig-Domingo, Manuel, Soto, Alfonso, Venegas, Eva, Vilchez, Ricardo, Blanco, Concepción, Cordido, Fernando, Lucas, Tomás, Marazuela, Mónica, Casany, Rosa, Cuatrecasas, Guillem, Fajardo, Carmen, Gálvez, María Ángeles, Maraver, Silvia, Martín, Tomás, Romero, Enrique, Paja, Miguel, Picó, Antonio, Bernabeu, Ignacio, and Resmini, Eugenia

Published
2016
Full Text
View/download PDF

12. The Molecular Registry of Pituitary Adenomas (REMAH): A bet by Spanish Endocrinology for the future of individualized medicine and translational research

Author

Luque, Raúl M., Ibáñez-Costa, Alejandro, Sánchez-Tejada, Laura, Rivero-Cortés, Esther, Robledo, Mercedes, Madrazo-Atutxa, Ainara, Mora, Mireia, Álvarez, Clara V., Lucas-Morante, Tomás, Álvarez-Escolá, Cristina, Fajardo, Carmen, Castaño, Luis, Gaztambide, Sonia, Venegas-Moreno, Eva, Soto-Moreno, Alfonso, Gálvez, María Ángeles, Salvador, Javier, Valassi, Elena, Webb, Susan M., Picó, Antonio, Puig-Domingo, Manel, Gilabert, Montserrat, Bernabéu, Ignacio, Marazuela, Mónica, Leal-Cerro, Alfonso, and Castaño, Justo P.

Published
2016
Full Text
View/download PDF

15. ROMI - Public Deliverables

Author

Minchin, Jonathan, Camprodon, Guillem, Barberan, Victor, Vernoux, Teva, Besnard, Fabrice, Legrand, Jonathan, Godin, Christophe, Mirande, Katia, Hafner, Verena, Pico, Antonio, Schillaci, Guido, Karkides, Laurine, Chatelain, Laurent, Degrand, Olivier, Chevenet, Chloé, Colliaux, David, Wintz, Timothée, Lahlou, Aliénor, Garlanda, Lisa, Macé, Aurèle, Boari, Douglas, Pan, Haolin, and Hanappe, Peter

Abstract

This archive contains the public Deliverables of the EU project Robotics for Microfarms (ROMI) D1.2 - Management document - The Rover - v1.pdf D1.2 - Management Document - The Rover - v2.pdf D1.3 - Management document - The Farmers Dashboard - v1.pdf D1.3 - Management Document - The Farmers Dashboard - v2.pdf D1.4 - Management document - The 3D Plant Imager - v1.pdf D1.4 - Management Document - The 3D Plant Imager - v2.pdf D2.1 - First LettuceThink Prototype.pdf D2.2 - Second LettuceThink prototype.pdf D2.3 - Detailed documentation of the rover.pdf D2.4 - LettuceThink Robot.pdf D3.1 - First NERO Prototype.pdf D3.2 - Second prototype Farmers Dashboard.pdf D3.3 - Detailed documentation of NERO.pdf D3.4 - NERO aerial robotic solution for microfarms.pdf D4.2 - Report on the adaptive learning system.pdf D4.3 - Final report on the adaptive learning system.pdf D4.4 - Adaptive Learning for the LettuceThink Robot.pdf D5.1 - Demonstration 3D Image Segmentation Weeding.pdf D5.2 - Demonstration of enhanced 3D segmentation for weeding.pdf D5.3 - Demonstration 3D Reconstruction Plants.pdf D5.4 - Demonstration of 3d reconstruction of plants over time (4d) to follow plant growth.pdf D5.5 - Report on the computer vision algorithms and their applications - OLD.pdf D5.5 - Report on the computer vision algorithms and their applications.pdf D6.1 - Simplified Model Arabidopsis.pdf D6.2 - Model of crop species 1.pdf D6.3 - Results of trained models.pdf D6.4 - Realistic model of Arabidopsis based on botanical measurements and extension to new plant species.pdf D6.4 - Supplementary Doc.pdf D6.5 - Development and assessment of a validation method for assessment of plant trait extraction from the ROMI pipeline.pdf D6.5 - Supplementary Doc.pdf D7.1 - Description Experimental Set-up Outdoor Field Studies.pdf D7.2 - Intermediate Report Field Studies 1.pdf D7.3 - Intermediate report on the field studies II.pdf D7.4 - Final report on the field studies.pdf D8.1 - Data Management Plan.pdf D8.2 - Intermediate Dissemination Report I.pdf D8.3 - Intermediate dissemination report II.pdf D8.5 - Final dissemination report.pdf &nbsp

Published
2022
Full Text
View/download PDF

18. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency:Overview of 15 809 GH-Treated Patients

Author

Johannsson, Gudmundur, Touraine, Philippe, Feldt-Rasmussen, Ulla, Pico, Antonio, Vila, Greisa, Mattsson, Anders F., Carlsson, Martin, Korbonits, Márta, Van Beek, Andr Crossed D.sign© P., Wajnrajch, Michael P., Gomez, Roy, Yuen, Kevin C.J., Johannsson, Gudmundur, Touraine, Philippe, Feldt-Rasmussen, Ulla, Pico, Antonio, Vila, Greisa, Mattsson, Anders F., Carlsson, Martin, Korbonits, Márta, Van Beek, Andr Crossed D.sign© P., Wajnrajch, Michael P., Gomez, Roy, and Yuen, Kevin C.J.

Abstract

Context: Data on long-term safety of growth hormone (GH) replacement in adults with GH deficiency (GHD) are needed. Objective: We aimed to evaluate the safety of GH in the full KIMS (Pfizer International Metabolic Database) cohort. Methods: The worldwide, observational KIMS study included adults and adolescents with confirmed GHD. Patients were treated with GH (Genotropin [somatropin]; Pfizer, NY) and followed through routine clinical practice. Adverse events (AEs) and clinical characteristics (eg, lipid profile, glucose) were collected. Results: A cohort of 15 809 GH-treated patients were analyzed (mean follow-up of 5.3 years). AEs were reported in 51.2% of patients (treatment-related in 18.8%). Crude AE rate was higher in patients who were older, had GHD due to pituitary/hypothalamic tumors, or adult-onset GHD. AE rate analysis adjusted for age, gender, etiology, and follow-up time showed no correlation with GH dose. A total of 606 deaths (3.8%) were reported (146 by neoplasms, 71 by cardiac/vascular disorders, 48 by cerebrovascular disorders). Overall, de novo cancer incidence was comparable to that in the general population (standard incidence ratio 0.92; 95% CI, 0.83-1.01). De novo cancer risk was significantly lower in patients with idiopathic/congenital GHD (0.64; 0.43-0.91), but similar in those with pituitary/hypothalamic tumors or other etiologies versus the general population. Neither adult-onset nor childhood-onset GHD was associated with increased de novo cancer risks. Neutral effects were observed in lipids/fasting blood glucose levels. Conclusion: These final KIMS cohort data support the safety of long-term GH replacement in adults with GHD as prescribed in routine clinical practice.

Published
2022

19. Validation of a clinicopathological classification for the prediction of pituitary adenomas: a retrospective cohort study in a PTCOE from 2013 to 2020

Author

Arguello, Gordillo Thalia, primary, Miguel, Castro Garcia Jose, additional, Martinez, Gauffin Lucia, additional, Kuptsov, Artem, additional, Tejedo-Flors, Dolores, additional, Eugenia, Torregrosa-Quesada Maria, additional, Abarca, Olivas Javier, additional, Concepcion, Luis, additional, Aranda, Ignacio, additional, and Pico, Antonio, additional

Published
2022
Full Text
View/download PDF

20. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients

Author

Johannsson, Gudmundur, primary, Touraine, Philippe, additional, Feldt-Rasmussen, Ulla, additional, Pico, Antonio, additional, Vila, Greisa, additional, Mattsson, Anders F, additional, Carlsson, Martin, additional, Korbonits, Márta, additional, van Beek, André P, additional, Wajnrajch, Michael P, additional, Gomez, Roy, additional, and Yuen, Kevin C J, additional

Published
2022
Full Text
View/download PDF

25. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement

Author

Casanueva, Felipe F, Barkan, Ariel L., Buchfelder, Michael, Klibanski, Anne, Laws, Edward R., Loeffler, Jay S., Melmed, Shlomo, Mortini, Pietro, Wass, John, Giustina, Andrea, Lomba, Alin Abreu, Abucham, Julio, Alvarez Escola, Cristina, Barkan, Ariel L, Beckers, Albert, Ben Shlomo, Anat, Bernabeu, Ignacio, Bidlingmaier, Martin, Biermasz, Nienke, Biller, Beverly, Boguszewski, Cesar Luiz, Bolanowski, Marek, Bollerslev, Jens, Bonert, Vivien, Bronstein, Marcello, Bruno, Oscar D., Carmichael, John D., Caron, Philippe, Chanson, Philippe, Casanueva, Felipe F., Clayton, Richard N., Colao, Annamaria, Cordido, Fernando, de Marinis, Laura, Fahlbusch, Rudolf, Fleseriu, Maria, Formenti, Anna Maria, Freda, Pamela U., Fukuoka, Hidenori, Ghigo, Ezio, Greenman, Yona, Grineva, Elena, Grossman, Ashley, Gurnell, Mark, Heaney, Anthony, Hoffman, Andrew R., Ilovayskaya, Irena, Johannsson, Gudmundur, Kadioglu, Pinar, Karavitaki, Niki, Katznelson, Laurence, Kelestimur, Fahrettin, Kelly, Daniel F., Ken, Ho, Krsek, Michal, Lacroix, Andre, Stevenloeffler, Jay, Losa, Marco, Jã¸rgensen, Jens Otto, Luger, Anton, Mallea Gil, Susana, Mamelak, Adam, Mazziotti, Gherardo, Mccormack, Ann, Mercado, Moises, Neggers, Sebastian, Ning, Guang, Oyesiku, Nelson M., Popovic, Vera, Petakov, Milan, Petersenn, Stephan, Pfeifer, Misa, Pico, Antonio, Domingo, Manuel Puig, Raverot, Gã©rald, Reincke, Martin, Gadelha, Monica Roberto, Salvatori, Roberto, Samson, Susan L., Shimatsu, Akira, Shimon, Ilan, Stewart, Paul, Strasburger, Christian, Swearingen, Brooke, Trainer, Peter, Tritos, Nicholas A., Tsagarakis, Stylianos, van der Lely, A. J., Vilar, Lucio, Villar Taibo, Rocio, Zatelli, Maria Chiara, Casanueva, Felipe F., Barkan, Ariel L., Buchfelder, Michael, Klibanski, Anne, Laws, Edward R., Loeffler, Jay S., Melmed, Shlomo, Mortini, Pietro, Wass, John, Giustina, Andrea, Lomba, Alin Abreu, Abucham, Julio, Alvarez-Escola, Cristina, Barkan, Ariel L, Beckers, Albert, Ben-Shlomo, Anat, Bernabeu, Ignacio, Bidlingmaier, Martin, Biermasz, Nienke, Biller, Beverly, Boguszewski, Cesar Luiz, Bolanowski, Marek, Bollerslev, Jen, Bonert, Vivien, Bronstein, Marcello, Bruno, Oscar D., Carmichael, John D., Caron, Philippe, Chanson, Philippe, Clayton, Richard N., Colao, Annamaria, Cordido, Fernando, De Marinis, Laura, Fahlbusch, Rudolf, Fleseriu, Maria, Formenti, Anna Maria, Freda, Pamela U., Fukuoka, Hidenori, Ghigo, Ezio, Greenman, Yona, Grineva, Elena, Grossman, Ashley, Gurnell, Mark, Heaney, Anthony, Hoffman, Andrew R., Ilovayskaya, Irena, Johannsson, Gudmundur, Kadioglu, Pinar, Karavitaki, Niki, Katznelson, Laurence, Kelestimur, Fahrettin, Kelly, Daniel F., Ken, Ho, Krsek, Michal, Lacroix, Andre, Stevenloeffler, Jay, Losa, Marco, Jørgensen, Jens Otto, Luger, Anton, Mallea-Gil, Susana, Mamelak, Adam, Mazziotti, Gherardo, Mccormack, Ann, Mercado, Moise, Neggers, Sebastian, Ning, Guang, Oyesiku, Nelson M., Popovic, Vera, Petakov, Milan, Petersenn, Stephan, Pfeifer, Misa, Pico, Antonio, Domingo, Manuel Puig, Raverot, Gérald, Reincke, Martin, Gadelha, Monica Roberto, Salvatori, Roberto, Samson, Susan L., Shimatsu, Akira, Shimon, Ilan, Stewart, Paul, Strasburger, Christian, Swearingen, Brooke, Trainer, Peter, Tritos, Nicholas A., Tsagarakis, Styliano, van der Lely, A. J., Vilar, Lucio, Villar-Taibo, Rocio, Zatelli, Maria Chiara, Gurnell, Mark [0000-0001-5745-6832], Apollo - University of Cambridge Repository, and Ho, Ken

Subjects
Male, Pituitary disorder, Pituitary Diseases, Thyrotropinomas, Endocrinology, Diabetes and Metabolism, Pituitary Disease, Pituitary neoplasm, Session (web analytics), Task (project management), 0302 clinical medicine, Endocrinology, Medicine, Pituitary Neoplasm, Societies, Medical, media_common, Gonadotropin, Cushing’s disease, Cushing’s disease, 3. Good health, Diabetes and Metabolism, Treatment Outcome, Work (electrical), Pituitary Gland, Female, Cushing's disease, Human, United State, medicine.medical_specialty, media_common.quotation_subject, Thyrotropinoma, 030209 endocrinology & metabolism, NO, Pituitary radiotherapy, 03 medical and health sciences, Excellence, Medical, Acromegaly, Gonadotropins, Transsphenoidal surgery, Humans, Pituitary ACTH Hypersecretion, Pituitary Neoplasms, United States, Medical education, business.industry, Pituitary ACTH hypersecretion, Pituitary tumors, Correction, medicine.disease, Surgery, Societies, business, 030217 neurology & neurosurgery
Abstract

Introduction: With the goal of generate uniform criteria among centers dealing with pituitary tumors and to enhance patient care, the Pituitary Society decided to generate criteria for developing Pituitary Tumors Centers of Excellence (PTCOE). Methods: To develop that task, a group of ten experts served as a Task Force and through two years of iterative work an initial draft was elaborated. This draft was discussed, modified and finally approved by the Board of Directors of the Pituitary Society. Such document was presented and debated at a specific session of the Congress of the Pituitary Society, Orlando 2017, and suggestions were incorporated. Finally the document was distributed to a large group of global experts that introduced further modifications with final endorsement. Results: After five years of iterative work a document with the ideal criteria for a PTCOE is presented. Conclusions: Acknowledging that very few centers in the world, if any, likely fulfill the requirements here presented, the document may be a tool to guide improvements of care delivery to patients with pituitary disorders. All these criteria must be accommodated to the regulations and organization of Health of a given country.

Published
2017

29. Vitamin D Deficiency, Lipid Profile, Adipokines, Intrahepatic Lipids and Intima-Media Thickness in Men with HIV Infection

Author

Moreno-Perez, Oscar, primary, Serna-Candel, Carmen, additional, Sanchez-Ortiga, Ruth, additional, Escoin, Corina, additional, Portilla, Joaquin, additional, Boix, Vicente, additional, Merino, Esperanza, additional, Reus, Sergio, additional, Alfayate, Rocio, additional, Mauri, Monserrat, additional, and Pico, Antonio M, additional

Published
2011
Full Text
View/download PDF

31. Male pituitary–gonadal axis dysfunction in post‐acute COVID‐19 syndrome—Prevalence and associated factors: A Mediterranean case series.

Author

Moreno‐Perez, Oscar, Merino, Esperanza, Alfayate, Rocio, Torregrosa, Maria Eugenia, Andres, Mariano, Leon‐Ramirez, Jose‐Manuel, Boix, Vicente, Gil, Joan, and Pico, Antonio

Subjects
POST-acute COVID-19 syndrome, SARS-CoV-2, CORONAVIRUS diseases, GONADAL diseases, TESTIS physiology, SERTOLI cells, COVID-19
Abstract

Objective: Severe acute respiratory syndrome coronavirus 2 through angiotensin‐converting enzyme 2 receptor can harm testes function. The objectives were to analyse the prevalence of low serum testosterone (LT) and impaired fertility potential (Leydig and Sertoli cells dysfunction, respectively) in coronavirus disease 2019 (COVID‐19) male survivors and to evaluate acute infection‐related associated factors. Also, we explore its association with post‐acute COVID‐19 syndrome (PCS) and quality of life (QOL). Materials and Methods: Male adults recovered from polymerase chain reaction‐confirmed COVID‐19 were offered a structured evaluation 8–12 weeks after recovery. The main outcome measure(s) were as follows: LT, defined as total testosterone (TT) < 2 ng/ml or if TT levels 2–4 ng/ml as calculated free testosterone < 6.36 ng/dl; Sertoli cell dysfunction was defined as inhibin‐B < 89 pg/ml. Secondary outcome‐associated factors were analysed by multiple logistic regression (odds ratio; 95% confidence interval [CI]). QOL was evaluated by SF‐36 v.2. Results: One hundred and forty‐three patients were evaluated at a median (interquartile range) of 77 days (72–83) after disease onset; 72% of them recovered from severe pneumonia. LT was detected in 41 patients (28.7%; 95% CI: 21.8–36.5). Low levels of inhibin‐B were detected in 25 patients (18.1%; 95% CI: 12.5–25.3). After multivariate adjustment, obesity and hypokalaemia were associated with LT, whereas age more than 65 was an independent predictor of Sertoli cell dysfunction. LT or Sertoli cell dysfunction was not associated with PCS. Patients with LT had a lower score in four domains of QOL. Conclusions: Prevalence of male LT and impaired fertility potential in COVID‐19 survivors is high in the medium term. Traditional risk factors and severity markers for COVID‐19 could be predictive. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

34. Data mining analyses for precision medicine in acromegaly

Author

Marques-Pamies, Montserrat, primary, Gil, Joan, additional, Jorda, Mireia, additional, Antonio, Sampedro-Nunez Miguel, additional, Webb, Susan, additional, Serra, Guillermo, additional, Salinas, Vert Isabel, additional, Blanco, Alberto, additional, Valassi, Elena, additional, Maria, Martel Duguech Luciana, additional, Carrato, Cristina, additional, Pico, Antonio, additional, García-Martínez, Araceli, additional, Simó-Servat, Andreu, additional, Biagetti, Betina, additional, Villabona, Carles, additional, Camara-Gómez, Rosa, additional, Fajardo-Montañana, Carmen, additional, Lamas, Cristina, additional, Alvarez, Clara, additional, Bernabeu, Ignacio, additional, Marazuela, Monica, additional, and Puig-Domingo, Manel, additional

Published
2020
Full Text
View/download PDF

38. Characterizing stratigraphic traps using waveform classification of seismic facies: A case study of Shallow Reservoir, Kuwait.

Author

Pico, Antonio, primary, Taqi, Fatma, additional, Marzouqpha, Al-Rashdan Saad Rasheed, additional, AlDoub, Abdulaziz S, additional, Ahmad, Alboloushi, additional, Al-Dohaiem, Khali, additional, Tyagi, Aditya, additional, Pabitra, Saikia, additional, Kharghoria, Arun, additional, Al-Rabah, Abdullah, additional, and Zhang, Ian, additional

Published
2019
Full Text
View/download PDF

40. Is the molecular study of pituitary transcription factors useful in the identification of Pituitary Neuroendocrine Tumor subtypes according to the new WHO 2017 criteria?

Author

Garcia-Martinez, Araceli, primary, Martinez-Lopez, Sebastian, additional, Torregrosa, Maria Eugenia, additional, Silva, Sandra, additional, Fajardo, Carmen, additional, Camara, Rosa, additional, Lamas, Cristina, additional, Aranda, Ignacio, additional, and Pico, Antonio, additional

Published
2019
Full Text
View/download PDF

41. Epigenetic regulation by miRNAs in corticotroph tumors

Author

Garcia-Martinez, Araceli, primary, Lopez-Munoz, Beatriz, additional, Fajardo, Carmen, additional, Camara, Rosa, additional, Lamas, Cristina, additional, Torregrosa, Maria Eugenia, additional, Aranda, Ignacio, additional, and Pico, Antonio, additional

Published
2019
Full Text
View/download PDF

42. Silent somatotroph tumors

Author

Garcia-Martinez, Araceli, primary, Lloret, Adriana, additional, Torregrosa, Maria Eugenia, additional, Silva, Sandra, additional, Lamas, Cristina, additional, Fajardo, Carmen, additional, Camara, Rosa, additional, Aranda, Ignacio, additional, and Pico, Antonio, additional

Published
2019
Full Text
View/download PDF

45. Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV

Author

Portilla, Joaquin, Moreno-Perez, Oscar, Serna-Candel, Carmen, Escoin, Corina, Alfayate, Rocio, Reus, Sergio, Merino, Esperanza, Boix, Vicente, Giner, Livia, Sanchez-Paya, Jose, and Pico, Antonio

Subjects
Diabetes -- Physiological aspects, Vitamin D deficiency -- Complications and side effects, Atherosclerosis -- Risk factors, HIV infection -- Physiological aspects, Health
Abstract

Introduction: Vitamin D insufficiency (VDI) has been associated with increased cardiovascular risk in the non-HIV population. This study evaluates the relationship among serum 25-hydroxyvitamin D [25(OH)D] levels, cardiovascular risk factors, adipokines, antiviral therapy (ART) and subclinical atherosclerosis in HIV-infected males. Methods: A cross-sectional study in ambulatory care was made in non-diabetic patients living with HIV. VDI was defined as 25(OH)D serum levels Results: Eighty-nine patients were included (age 42 ± 8 years), 18.9% were in CDC (US Centers for Disease Control and Prevention) stage C and 75 were on ART. VDI was associated with ART exposure, sedentary lifestyle, higher triglycerides levels and PAI-I. In univariate analysis, VDI was associated with greater common C-IMT. The multivariate linear regression model, adjusted by confounding factors, revealed an independent association between common C-IMT and patient age, time of exposure to protease inhibitors (PIs) and impaired fasting glucose (IFG). In contrast, there were no independent associations between common C-IMT and VDI or inflammatory and endothelial markers. Conclusions: VDI was not independently associated with subclinical atherosclerosis in non-diabetic males living with HIV. Older age, a longer exposure to PIs, and IFG were independent factors associated with common C-IMT in this population. Keywords: atherosclerosis; vitamin D insufficiency; carotid intima media thickness; HIV; antiretroviral treatment; adipokines., Introduction Vitamin D insufficiency (VDI) is common in the general population [1]. Its estimated prevalence in people living with HIV is high, ranging from 70.3 to 83.7% [2,3]. Chronic inflammation [...]

Published
2014
Full Text
View/download PDF

47. Molecular profiling for assistance to pharmacological treatment of acromegaly

Author

Puig-Domingo, Manuel, primary, Gil, Joan, additional, Sampedro, Miguel, additional, Webb, Susan M, additional, Serra, Guillermo, additional, Salinas, Isabel, additional, Blanco, Alberto, additional, Marques-Pamies, Montse, additional, Pico, Antonio, additional, Garcia-Martinez, Araceli, additional, Blanco, Concepcion, additional, Del, Pozo Carlos, additional, Obiols, Gabriel, additional, Alvarez-Escola, Cristina, additional, Camara, Rosa, additional, Fajardo, Carmen, additional, Luque, Raul, additional, Castano, Justo, additional, Robledo, Mercedes, additional, Jorda, Mireia, additional, Bernabeu, Ignacio, additional, and Marazuela, Monica, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results